The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Erectile Dysfunction Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Erectile Dysfunction Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Erectile Dysfunction Treatment market size is estimated to be worth US$ 4995.6 million in 2021 and is forecast to a readjusted size of USD 7328.5 million by 2028 with a CAGR of 5.6% during review period. Hospital accounting for % of the Erectile Dysfunction Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral Treatment segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Erectile Dysfunction Treatment include Boston Scientific, Coloplast Group, Zephyr Surgical Implants, Medispec, and Augusta Medical Systems, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Erectile Dysfunction Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral Treatment
Penis Implant
Vacuum Shrinkage Device
Shock Wave Therapy
Market segment by Application, can be divided into
Hospital
Specialist Clinic
Other
Market segment by players, this report covers
Boston Scientific
Coloplast Group
Zephyr Surgical Implants
Medispec
Augusta Medical Systems
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
KARL STORZ
Dong-A ST
Metuchen Pharma
Seoul Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Erectile Dysfunction Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Erectile Dysfunction Treatment, with revenue, gross margin and global market share of Erectile Dysfunction Treatment from 2019 to 2022.
Chapter 3, the Erectile Dysfunction Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Erectile Dysfunction Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Erectile Dysfunction Treatment research findings and conclusion, appendix and data source.
Geographical Area
Global
The Erectile Dysfunction Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Erectile Dysfunction Treatment market size is estimated to be worth US$ 4995.6 million in 2021 and is forecast to a readjusted size of USD 7328.5 million by 2028 with a CAGR of 5.6% during review period. Hospital accounting for % of the Erectile Dysfunction Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral Treatment segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Erectile Dysfunction Treatment include Boston Scientific, Coloplast Group, Zephyr Surgical Implants, Medispec, and Augusta Medical Systems, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Erectile Dysfunction Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral Treatment
Penis Implant
Vacuum Shrinkage Device
Shock Wave Therapy
Market segment by Application, can be divided into
Hospital
Specialist Clinic
Other
Market segment by players, this report covers
Boston Scientific
Coloplast Group
Zephyr Surgical Implants
Medispec
Augusta Medical Systems
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
KARL STORZ
Dong-A ST
Metuchen Pharma
Seoul Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Erectile Dysfunction Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Erectile Dysfunction Treatment, with revenue, gross margin and global market share of Erectile Dysfunction Treatment from 2019 to 2022.
Chapter 3, the Erectile Dysfunction Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Erectile Dysfunction Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Erectile Dysfunction Treatment research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Erectile Dysfunction Treatment
1.2 Classification of Erectile Dysfunction Treatment by Type
1.2.1 Overview: Global Erectile Dysfunction Treatment Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Erectile Dysfunction Treatment Revenue Market Share by Type in 2021
1.2.3 Oral Treatment
1.2.4 Penis Implant
1.2.5 Vacuum Shrinkage Device
1.2.6 Shock Wave Therapy
1.3 Global Erectile Dysfunction Treatment Market by Application
1.3.1 Overview: Global Erectile Dysfunction Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Other
1.4 Global Erectile Dysfunction Treatment Market Size & Forecast
1.5 Global Erectile Dysfunction Treatment Market Size and Forecast by Region
1.5.1 Global Erectile Dysfunction Treatment Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Erectile Dysfunction Treatment Market Size by Region, (2017-2022)
1.5.3 North America Erectile Dysfunction Treatment Market Size and Prospect (2017-2028)
1.5.4 Europe Erectile Dysfunction Treatment Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Erectile Dysfunction Treatment Market Size and Prospect (2017-2028)
1.5.6 South America Erectile Dysfunction Treatment Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Erectile Dysfunction Treatment Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Erectile Dysfunction Treatment Market Drivers
1.6.2 Erectile Dysfunction Treatment Market Restraints
1.6.3 Erectile Dysfunction Treatment Trends Analysis
2 Company Profiles
2.1 Boston Scientific
2.1.1 Boston Scientific Details
2.1.2 Boston Scientific Major Business
2.1.3 Boston Scientific Erectile Dysfunction Treatment Product and Solutions
2.1.4 Boston Scientific Erectile Dysfunction Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Boston Scientific Recent Developments and Future Plans
2.2 Coloplast Group
2.2.1 Coloplast Group Details
2.2.2 Coloplast Group Major Business
2.2.3 Coloplast Group Erectile Dysfunction Treatment Product and Solutions
2.2.4 Coloplast Group Erectile Dysfunction Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Coloplast Group Recent Developments and Future Plans
2.3 Zephyr Surgical Implants
2.3.1 Zephyr Surgical Implants Details
2.3.2 Zephyr Surgical Implants Major Business
2.3.3 Zephyr Surgical Implants Erectile Dysfunction Treatment Product and Solutions
2.3.4 Zephyr Surgical Implants Erectile Dysfunction Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Zephyr Surgical Implants Recent Developments and Future Plans
2.4 Medispec
2.4.1 Medispec Details
2.4.2 Medispec Major Business
2.4.3 Medispec Erectile Dysfunction Treatment Product and Solutions
2.4.4 Medispec Erectile Dysfunction Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Medispec Recent Developments and Future Plans
2.5 Augusta Medical Systems
2.5.1 Augusta Medical Systems Details
2.5.2 Augusta Medical Systems Major Business
2.5.3 Augusta Medical Systems Erectile Dysfunction Treatment Product and Solutions
2.5.4 Augusta Medical Systems Erectile Dysfunction Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Augusta Medical Systems Recent Developments and Future Plans
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Erectile Dysfunction Treatment Product and Solutions
2.6.4 Eli Lilly Erectile Dysfunction Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Eli Lilly Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Erectile Dysfunction Treatment Product and Solutions
2.7.4 Pfizer Erectile Dysfunction Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Pfizer Recent Developments and Future Plans
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business
2.8.3 Bayer Erectile Dysfunction Treatment Product and Solutions
2.8.4 Bayer Erectile Dysfunction Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Bayer Recent Developments and Future Plans
2.9 BaiYunShan General Factory
2.9.1 BaiYunShan General Factory Details
2.9.2 BaiYunShan General Factory Major Business
2.9.3 BaiYunShan General Factory Erectile Dysfunction Treatment Product and Solutions
2.9.4 BaiYunShan General Factory Erectile Dysfunction Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 BaiYunShan General Factory Recent Developments and Future Plans
2.10 S.K. Chemicals
2.10.1 S.K. Chemicals Details
2.10.2 S.K. Chemicals Major Business
2.10.3 S.K. Chemicals Erectile Dysfunction Treatment Product and Solutions
2.10.4 S.K. Chemicals Erectile Dysfunction Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 S.K. Chemicals Recent Developments and Future Plans
2.11 Teva Pharma
2.11.1 Teva Pharma Details
2.11.2 Teva Pharma Major Business
2.11.3 Teva Pharma Erectile Dysfunction Treatment Product and Solutions
2.11.4 Teva Pharma Erectile Dysfunction Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Teva Pharma Recent Developments and Future Plans
2.12 KARL STORZ
2.12.1 KARL STORZ Details
2.12.2 KARL STORZ Major Business
2.12.3 KARL STORZ Erectile Dysfunction Treatment Product and Solutions
2.12.4 KARL STORZ Erectile Dysfunction Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 KARL STORZ Recent Developments and Future Plans
2.13 Dong-A ST
2.13.1 Dong-A ST Details
2.13.2 Dong-A ST Major Business
2.13.3 Dong-A ST Erectile Dysfunction Treatment Product and Solutions
2.13.4 Dong-A ST Erectile Dysfunction Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Dong-A ST Recent Developments and Future Plans
2.14 Metuchen Pharma
2.14.1 Metuchen Pharma Details
2.14.2 Metuchen Pharma Major Business
2.14.3 Metuchen Pharma Erectile Dysfunction Treatment Product and Solutions
2.14.4 Metuchen Pharma Erectile Dysfunction Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Metuchen Pharma Recent Developments and Future Plans
2.15 Seoul Pharma
2.15.1 Seoul Pharma Details
2.15.2 Seoul Pharma Major Business
2.15.3 Seoul Pharma Erectile Dysfunction Treatment Product and Solutions
2.15.4 Seoul Pharma Erectile Dysfunction Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Seoul Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Erectile Dysfunction Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Erectile Dysfunction Treatment Players Market Share in 2021
3.2.2 Top 10 Erectile Dysfunction Treatment Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Erectile Dysfunction Treatment Players Head Office, Products and Services Provided
3.4 Erectile Dysfunction Treatment Mergers & Acquisitions
3.5 Erectile Dysfunction Treatment New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Erectile Dysfunction Treatment Revenue and Market Share by Type (2017-2022)
4.2 Global Erectile Dysfunction Treatment Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Erectile Dysfunction Treatment Revenue Market Share by Application (2017-2022)
5.2 Global Erectile Dysfunction Treatment Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Erectile Dysfunction Treatment Revenue by Type (2017-2028)
6.2 North America Erectile Dysfunction Treatment Revenue by Application (2017-2028)
6.3 North America Erectile Dysfunction Treatment Market Size by Country
6.3.1 North America Erectile Dysfunction Treatment Revenue by Country (2017-2028)
6.3.2 United States Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
6.3.3 Canada Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
6.3.4 Mexico Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Erectile Dysfunction Treatment Revenue by Type (2017-2028)
7.2 Europe Erectile Dysfunction Treatment Revenue by Application (2017-2028)
7.3 Europe Erectile Dysfunction Treatment Market Size by Country
7.3.1 Europe Erectile Dysfunction Treatment Revenue by Country (2017-2028)
7.3.2 Germany Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
7.3.3 France Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
7.3.5 Russia Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
7.3.6 Italy Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Erectile Dysfunction Treatment Revenue by Type (2017-2028)
8.2 Asia-Pacific Erectile Dysfunction Treatment Revenue by Application (2017-2028)
8.3 Asia-Pacific Erectile Dysfunction Treatment Market Size by Region
8.3.1 Asia-Pacific Erectile Dysfunction Treatment Revenue by Region (2017-2028)
8.3.2 China Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
8.3.3 Japan Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
8.3.4 South Korea Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
8.3.5 India Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
8.3.7 Australia Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Erectile Dysfunction Treatment Revenue by Type (2017-2028)
9.2 South America Erectile Dysfunction Treatment Revenue by Application (2017-2028)
9.3 South America Erectile Dysfunction Treatment Market Size by Country
9.3.1 South America Erectile Dysfunction Treatment Revenue by Country (2017-2028)
9.3.2 Brazil Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
9.3.3 Argentina Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Erectile Dysfunction Treatment Revenue by Type (2017-2028)
10.2 Middle East & Africa Erectile Dysfunction Treatment Revenue by Application (2017-2028)
10.3 Middle East & Africa Erectile Dysfunction Treatment Market Size by Country
10.3.1 Middle East & Africa Erectile Dysfunction Treatment Revenue by Country (2017-2028)
10.3.2 Turkey Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
10.3.4 UAE Erectile Dysfunction Treatment Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Erectile Dysfunction Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Erectile Dysfunction Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Erectile Dysfunction Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Erectile Dysfunction Treatment Revenue (USD Million) by Region (2017-2022)
Table 5. Global Erectile Dysfunction Treatment Revenue Market Share by Region (2023-2028)
Table 6. Boston Scientific Corporate Information, Head Office, and Major Competitors
Table 7. Boston Scientific Major Business
Table 8. Boston Scientific Erectile Dysfunction Treatment Product and Solutions
Table 9. Boston Scientific Erectile Dysfunction Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Coloplast Group Corporate Information, Head Office, and Major Competitors
Table 11. Coloplast Group Major Business
Table 12. Coloplast Group Erectile Dysfunction Treatment Product and Solutions
Table 13. Coloplast Group Erectile Dysfunction Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Zephyr Surgical Implants Corporate Information, Head Office, and Major Competitors
Table 15. Zephyr Surgical Implants Major Business
Table 16. Zephyr Surgical Implants Erectile Dysfunction Treatment Product and Solutions
Table 17. Zephyr Surgical Implants Erectile Dysfunction Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Medispec Corporate Information, Head Office, and Major Competitors
Table 19. Medispec Major Business
Table 20. Medispec Erectile Dysfunction Treatment Product and Solutions
Table 21. Medispec Erectile Dysfunction Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Augusta Medical Systems Corporate Information, Head Office, and Major Competitors
Table 23. Augusta Medical Systems Major Business
Table 24. Augusta Medical Systems Erectile Dysfunction Treatment Product and Solutions
Table 25. Augusta Medical Systems Erectile Dysfunction Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 27. Eli Lilly Major Business
Table 28. Eli Lilly Erectile Dysfunction Treatment Product and Solutions
Table 29. Eli Lilly Erectile Dysfunction Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Pfizer Corporate Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer Erectile Dysfunction Treatment Product and Solutions
Table 33. Pfizer Erectile Dysfunction Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Bayer Corporate Information, Head Office, and Major Competitors
Table 35. Bayer Major Business
Table 36. Bayer Erectile Dysfunction Treatment Product and Solutions
Table 37. Bayer Erectile Dysfunction Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. BaiYunShan General Factory Corporate Information, Head Office, and Major Competitors
Table 39. BaiYunShan General Factory Major Business
Table 40. BaiYunShan General Factory Erectile Dysfunction Treatment Product and Solutions
Table 41. BaiYunShan General Factory Erectile Dysfunction Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. S.K. Chemicals Corporate Information, Head Office, and Major Competitors
Table 43. S.K. Chemicals Major Business
Table 44. S.K. Chemicals Erectile Dysfunction Treatment Product and Solutions
Table 45. S.K. Chemicals Erectile Dysfunction Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Teva Pharma Corporate Information, Head Office, and Major Competitors
Table 47. Teva Pharma Major Business
Table 48. Teva Pharma Erectile Dysfunction Treatment Product and Solutions
Table 49. Teva Pharma Erectile Dysfunction Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. KARL STORZ Corporate Information, Head Office, and Major Competitors
Table 51. KARL STORZ Major Business
Table 52. KARL STORZ Erectile Dysfunction Treatment Product and Solutions
Table 53. KARL STORZ Erectile Dysfunction Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Dong-A ST Corporate Information, Head Office, and Major Competitors
Table 55. Dong-A ST Major Business
Table 56. Dong-A ST Erectile Dysfunction Treatment Product and Solutions
Table 57. Dong-A ST Erectile Dysfunction Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Metuchen Pharma Corporate Information, Head Office, and Major Competitors
Table 59. Metuchen Pharma Major Business
Table 60. Metuchen Pharma Erectile Dysfunction Treatment Product and Solutions
Table 61. Metuchen Pharma Erectile Dysfunction Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Seoul Pharma Corporate Information, Head Office, and Major Competitors
Table 63. Seoul Pharma Major Business
Table 64. Seoul Pharma Erectile Dysfunction Treatment Product and Solutions
Table 65. Seoul Pharma Erectile Dysfunction Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Global Erectile Dysfunction Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 67. Global Erectile Dysfunction Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 68. Breakdown of Erectile Dysfunction Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Erectile Dysfunction Treatment Players Head Office, Products and Services Provided
Table 70. Erectile Dysfunction Treatment Mergers & Acquisitions in the Past Five Years
Table 71. Erectile Dysfunction Treatment New Entrants and Expansion Plans
Table 72. Global Erectile Dysfunction Treatment Revenue (USD Million) by Type (2017-2022)
Table 73. Global Erectile Dysfunction Treatment Revenue Share by Type (2017-2022)
Table 74. Global Erectile Dysfunction Treatment Revenue Forecast by Type (2023-2028)
Table 75. Global Erectile Dysfunction Treatment Revenue by Application (2017-2022)
Table 76. Global Erectile Dysfunction Treatment Revenue Forecast by Application (2023-2028)
Table 77. North America Erectile Dysfunction Treatment Revenue by Type (2017-2022) & (USD Million)
Table 78. North America Erectile Dysfunction Treatment Revenue by Type (2023-2028) & (USD Million)
Table 79. North America Erectile Dysfunction Treatment Revenue by Application (2017-2022) & (USD Million)
Table 80. North America Erectile Dysfunction Treatment Revenue by Application (2023-2028) & (USD Million)
Table 81. North America Erectile Dysfunction Treatment Revenue by Country (2017-2022) & (USD Million)
Table 82. North America Erectile Dysfunction Treatment Revenue by Country (2023-2028) & (USD Million)
Table 83. Europe Erectile Dysfunction Treatment Revenue by Type (2017-2022) & (USD Million)
Table 84. Europe Erectile Dysfunction Treatment Revenue by Type (2023-2028) & (USD Million)
Table 85. Europe Erectile Dysfunction Treatment Revenue by Application (2017-2022) & (USD Million)
Table 86. Europe Erectile Dysfunction Treatment Revenue by Application (2023-2028) & (USD Million)
Table 87. Europe Erectile Dysfunction Treatment Revenue by Country (2017-2022) & (USD Million)
Table 88. Europe Erectile Dysfunction Treatment Revenue by Country (2023-2028) & (USD Million)
Table 89. Asia-Pacific Erectile Dysfunction Treatment Revenue by Type (2017-2022) & (USD Million)
Table 90. Asia-Pacific Erectile Dysfunction Treatment Revenue by Type (2023-2028) & (USD Million)
Table 91. Asia-Pacific Erectile Dysfunction Treatment Revenue by Application (2017-2022) & (USD Million)
Table 92. Asia-Pacific Erectile Dysfunction Treatment Revenue by Application (2023-2028) & (USD Million)
Table 93. Asia-Pacific Erectile Dysfunction Treatment Revenue by Region (2017-2022) & (USD Million)
Table 94. Asia-Pacific Erectile Dysfunction Treatment Revenue by Region (2023-2028) & (USD Million)
Table 95. South America Erectile Dysfunction Treatment Revenue by Type (2017-2022) & (USD Million)
Table 96. South America Erectile Dysfunction Treatment Revenue by Type (2023-2028) & (USD Million)
Table 97. South America Erectile Dysfunction Treatment Revenue by Application (2017-2022) & (USD Million)
Table 98. South America Erectile Dysfunction Treatment Revenue by Application (2023-2028) & (USD Million)
Table 99. South America Erectile Dysfunction Treatment Revenue by Country (2017-2022) & (USD Million)
Table 100. South America Erectile Dysfunction Treatment Revenue by Country (2023-2028) & (USD Million)
Table 101. Middle East & Africa Erectile Dysfunction Treatment Revenue by Type (2017-2022) & (USD Million)
Table 102. Middle East & Africa Erectile Dysfunction Treatment Revenue by Type (2023-2028) & (USD Million)
Table 103. Middle East & Africa Erectile Dysfunction Treatment Revenue by Application (2017-2022) & (USD Million)
Table 104. Middle East & Africa Erectile Dysfunction Treatment Revenue by Application (2023-2028) & (USD Million)
Table 105. Middle East & Africa Erectile Dysfunction Treatment Revenue by Country (2017-2022) & (USD Million)
Table 106. Middle East & Africa Erectile Dysfunction Treatment Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Erectile Dysfunction Treatment Picture
Figure 2. Global Erectile Dysfunction Treatment Revenue Market Share by Type in 2021
Figure 3. Oral Treatment
Figure 4. Penis Implant
Figure 5. Vacuum Shrinkage Device
Figure 6. Shock Wave Therapy
Figure 7. Erectile Dysfunction Treatment Revenue Market Share by Application in 2021
Figure 8. Hospital Picture
Figure 9. Specialist Clinic Picture
Figure 10. Other Picture
Figure 11. Global Erectile Dysfunction Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Erectile Dysfunction Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Erectile Dysfunction Treatment Revenue Market Share by Region (2017-2028)
Figure 14. Global Erectile Dysfunction Treatment Revenue Market Share by Region in 2021
Figure 15. North America Erectile Dysfunction Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Erectile Dysfunction Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Erectile Dysfunction Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Erectile Dysfunction Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Erectile Dysfunction Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Erectile Dysfunction Treatment Market Drivers
Figure 21. Erectile Dysfunction Treatment Market Restraints
Figure 22. Erectile Dysfunction Treatment Market Trends
Figure 23. Boston Scientific Recent Developments and Future Plans
Figure 24. Coloplast Group Recent Developments and Future Plans
Figure 25. Zephyr Surgical Implants Recent Developments and Future Plans
Figure 26. Medispec Recent Developments and Future Plans
Figure 27. Augusta Medical Systems Recent Developments and Future Plans
Figure 28. Eli Lilly Recent Developments and Future Plans
Figure 29. Pfizer Recent Developments and Future Plans
Figure 30. Bayer Recent Developments and Future Plans
Figure 31. BaiYunShan General Factory Recent Developments and Future Plans
Figure 32. S.K. Chemicals Recent Developments and Future Plans
Figure 33. Teva Pharma Recent Developments and Future Plans
Figure 34. KARL STORZ Recent Developments and Future Plans
Figure 35. Dong-A ST Recent Developments and Future Plans
Figure 36. Metuchen Pharma Recent Developments and Future Plans
Figure 37. Seoul Pharma Recent Developments and Future Plans
Figure 38. Global Erectile Dysfunction Treatment Revenue Share by Players in 2021
Figure 39. Erectile Dysfunction Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 40. Global Top 3 Players Erectile Dysfunction Treatment Revenue Market Share in 2021
Figure 41. Global Top 10 Players Erectile Dysfunction Treatment Revenue Market Share in 2021
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 43. Global Erectile Dysfunction Treatment Revenue Share by Type in 2021
Figure 44. Global Erectile Dysfunction Treatment Market Share Forecast by Type (2023-2028)
Figure 45. Global Erectile Dysfunction Treatment Revenue Share by Application in 2021
Figure 46. Global Erectile Dysfunction Treatment Market Share Forecast by Application (2023-2028)
Figure 47. North America Erectile Dysfunction Treatment Sales Market Share by Type (2017-2028)
Figure 48. North America Erectile Dysfunction Treatment Sales Market Share by Application (2017-2028)
Figure 49. North America Erectile Dysfunction Treatment Revenue Market Share by Country (2017-2028)
Figure 50. United States Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Canada Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Mexico Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Europe Erectile Dysfunction Treatment Sales Market Share by Type (2017-2028)
Figure 54. Europe Erectile Dysfunction Treatment Sales Market Share by Application (2017-2028)
Figure 55. Europe Erectile Dysfunction Treatment Revenue Market Share by Country (2017-2028)
Figure 56. Germany Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific Erectile Dysfunction Treatment Sales Market Share by Type (2017-2028)
Figure 62. Asia-Pacific Erectile Dysfunction Treatment Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific Erectile Dysfunction Treatment Revenue Market Share by Region (2017-2028)
Figure 64. China Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South Korea Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America Erectile Dysfunction Treatment Sales Market Share by Type (2017-2028)
Figure 71. South America Erectile Dysfunction Treatment Sales Market Share by Application (2017-2028)
Figure 72. South America Erectile Dysfunction Treatment Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East and Africa Erectile Dysfunction Treatment Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Erectile Dysfunction Treatment Sales Market Share by Application (2017-2028)
Figure 77. Middle East and Africa Erectile Dysfunction Treatment Revenue Market Share by Country (2017-2028)
Figure 78. Turkey Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. UAE Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
